id
stringlengths 1
5
| document_id
stringlengths 9
11
| text
stringlengths 6
739
| labels
list |
---|---|---|---|
501 | 22851646_6 | Chaos3 mammary tumor cells exhibit RAS hyperactivation and increased sensitivity to RAS pathway inhibitors . | [
"none"
] |
502 | 22851646_7 | These results indicate that spontaneous NF1 loss can drive breast cancer . | [
"none"
] |
503 | 22851646_8 | This should be informative for treatment of the significant fraction of patients whose tumors bear NF1 mutations . | [
"genomic instability and mutation"
] |
504 | 23197380_0 | Prohibiting angiogenesis is an important therapeutic approach for fighting cancer and other angiogenic related diseases . | [
"none"
] |
505 | 23197380_1 | Research focused on proteins that regulate abnormal angiogenesis has attracted intense interest in both academia and industry . | [
"none"
] |
506 | 23197380_2 | Such proteins are able to target several angiogenic factors concurrently , thereby increasing the possibility of therapeutic success . | [
"none"
] |
507 | 23197380_3 | Aquaporin-1 ( AQP1 ) is a water channel membrane protein that promotes tumour angiogenesis by allowing faster endothelial cell migration . | [
"none"
] |
508 | 23197380_4 | In this study we test the hypothesis that AQP1 inhibition impairs tumour growth in a mouse model of melanoma . | [
"none"
] |
509 | 23197380_5 | After validating the inhibitor efficacy of two different AQP1 specific siRNAs in cell cultures , RNA interference experiments were performed by intratumoural injections of AQP1 siRNAs in mice . | [
"none"
] |
510 | 23197380_6 | After 6 days of treatment , AQP1 siRNA treated tumours showed a 75 % reduction in volume when compared to controls . | [
"none"
] |
511 | 23197380_7 | AQP1 protein level , in AQP1 knockdown tumours , was around 75 % that of the controls and was associated with a significant 40 % reduced expression of the endothelial marker , Factor VIII . | [
"none"
] |
512 | 23197380_8 | Immunofluorescence analysis of AQP1 siRNA treated tumours showed a significantly lower microvessel density . | [
"inducing angiogenesis"
] |
513 | 23197380_9 | Time course experiments demonstrated that repeated injections of AQP1 siRNA over time are effective in sustaining the inhibition of tumour growth . | [
"none"
] |
514 | 23197380_10 | Finally , we have confirmed the role of AQP1 in sustaining an active endothelium during angiogenesis and we have shown that AQP1 reduction causes an increase in VEGF levels . | [
"inducing angiogenesis"
] |
515 | 23197380_11 | In conclusion , this study validates AQP1 as a pro-angiogenic protein , relevant for the therapy of cancer and other angiogenic-related diseases such as psoriasis , endometriosis , arthritis and atherosclerosis . | [
"inducing angiogenesis"
] |
516 | 22829774_0 | The Alternative Lengthening of Telomeres ( ALT ) pathway is a telomerase-independent pathway for telomere maintenance that is active in a significant subset of human cancers and in vitro immortalized cell lines . | [
"none"
] |
517 | 22829774_1 | ALT is thought to involve templated extension of telomeres through homologous recombination , but the genetic or epigenetic changes that unleash ALT are not known . | [
"none"
] |
518 | 22829774_2 | Recently , mutations in the ATRX/DAXX chromatin remodeling complex and histone H3.3 were found to correlate with features of ALT in pancreatic neuroendocrine cancers , pediatric glioblastomas , and other tumors of the central nervous system , suggesting that these mutations might contribute to the activation of the ALT pathway in these cancers . | [
"none"
] |
519 | 22829774_3 | We have taken a comprehensive approach to deciphering ALT by applying genomic , molecular biological , and cell biological approaches to a panel of 22 ALT cell lines , including cell lines derived in vitro . | [
"none"
] |
520 | 22829774_4 | Here we show that loss of ATRX protein and mutations in the ATRX gene are hallmarks of ALT-immortalized cell lines . | [
"genomic instability and mutation",
"enabling replicative immortality"
] |
521 | 22829774_5 | In addition , ALT is associated with extensive genome rearrangements , marked micronucleation , defects in the G2/M checkpoint , and altered double-strand break ( DSB ) repair . | [
"genomic instability and mutation",
"evading growth suppressors"
] |
522 | 22829774_6 | These attributes will facilitate the diagnosis and treatment of ALT positive human cancers . | [
"none"
] |
523 | 21044925_0 | BACKGROUND AND AIMS breast reconstruction with silicone prosthesis following nipple-sparing mastectomy has become widely accepted as a reconstruction option in women requiring mastectomy for cancer . | [
"none"
] |
524 | 21044925_1 | The purpose of this study was to evaluate the incidence and some factors influencing early local complications in patients undergoing NSM with immediate implant reconstruction . | [
"none"
] |
525 | 21044925_2 | MATERIAL AND METHODS prospective study was performed on a consecutive series of 214 breast reconstructions in 205 patients . | [
"none"
] |
526 | 21044925_3 | All complications during the six weeks after surgery were recorded. 42 prostheses were implanted after neoadjuvant chemotherapy , 27 patients previously had radiotherapy due to breast conserving surgery and in all other cases surgery was the pri-mary treatment for cancer . | [
"none"
] |
527 | 21044925_4 | RESULTS the overall six-week complication rate was 16% ( 35 ) and included : major skin flap necrosis ( 4% , 9 procedures ) , minor skin necrosis ( 3% , 7 ) , major infection ( 2% , 5 ) , minor infection ( 3% , 7 ) , prolonged seroma formation ( 3% , 6 ) , haematoma ( 1% , 2 ) and epidermolysis ( 1% , 2 ) . | [
"resisting cell death"
] |
528 | 21044925_5 | In 6% ( 12 ) reconstruction procedures explantation of prosthesis was done . | [
"none"
] |
529 | 21044925_6 | Neoadjuvant chemo-therapy and radiotherapy were not associated with higher rate of complications . | [
"none"
] |
530 | 21044925_7 | CONCLUSION nipple-sparing mastectomy with immediate implant reconstruction has acceptable morbidity rate in the hand of experienced oncoplastic surgeon and therefore should be considered as treatment option to women requiring mastectomy . | [
"none"
] |
531 | 22825251_0 | Exposure of cells to UV light from the sun causes the formation of pyrimidine dimers in DNA that have the potential to lead to mutation and cancer . | [
"none"
] |
532 | 22825251_1 | In humans , pyrimidine dimers are removed from the genome in the form of nt-long oligomers by concerted dual incisions . | [
"none"
] |
533 | 22825251_2 | Though nearly 50 y of excision repair research has uncovered many details of UV photoproduct damage recognition and removal , the fate of the excised oligonucleotides and , in particular , the ultimate fate of the chemically very stable pyrimidine dimers remain unknown . | [
"none"
] |
534 | 22825251_3 | Physiologically relevant UV doses introduce hundreds of thousands of pyrimidine dimers in diploid human cells , which are excised from the genome within h . | [
"none"
] |
535 | 22825251_4 | Once removed from the genome , " where do all the dimers go? " | [
"none"
] |
536 | 22825251_5 | In a recent study we addressed this question . | [
"none"
] |
537 | 22825251_6 | Although our study did not determine the fate of the dimer itself , it revealed that the excised is released from the duplex in a tight complex with the transcription/repair factor TFIIH . | [
"none"
] |
538 | 22825251_7 | This finding combined with recent reports that base and oligonucleotide products of the base and double-strand break repair pathways also make stable complexes with the cognate repair enzymes , and that these complexes activate the MAP kinase and checkpoint signaling pathways , respectively , raises the possibility that TFIIH-30-mer excision complexes may play a role in signaling reactions in response to UV damage . | [
"none"
] |
539 | 22395432_0 | We have recently proposed a new two-compartment model for understanding the Warburg effect in tumor metabolism . | [
"none"
] |
540 | 22395432_1 | In this model , glycolytic stromal cells produce mitochondrial fuels ( L-lactate and ketone bodies ) that are then transferred to oxidative epithelial cancer cells , driving OXPHOS and mitochondrial metabolism . | [
"none"
] |
541 | 22395432_2 | Thus , stromal catabolism fuels anabolic tumor growth via energy transfer . | [
"none"
] |
542 | 22395432_3 | We have termed this new cancer paradigm the " reverse Warburg effect, " because stromal cells undergo aerobic glycolysis , rather than tumor cells . | [
"none"
] |
543 | 22395432_4 | To assess whether this mechanism also applies during cancer cell metastasis , we analyzed the bioenergetic status of breast cancer lymph node metastases , by employing a series of metabolic protein markers . | [
"none"
] |
544 | 22395432_5 | For this purpose , we used MCT4 to identify glycolytic cells . | [
"none"
] |
545 | 22395432_6 | Similarly , we used TO MM20 and COX staining as markers of mitochondrial mass and OXPHOS activity , respectively . | [
"none"
] |
546 | 22395432_7 | Consistent with the " reverse Warburg effect, " our results indicate that metastatic breast cancer cells amplify oxidative mitochondrial metabolism ( OXPHOS ) and that adjacent stromal cells are glycolytic and lack detectable mitochondria . | [
"cellular energetics",
"activating invasion and metastasis"
] |
547 | 22395432_8 | Glycolytic stromal cells included cancer-associated fibroblasts , adipocytes and inflammatory cells . | [
"cellular energetics",
"tumor promoting inflammation"
] |
548 | 22395432_9 | Double labeling experiments with glycolytic ( MCT4 ) and oxidative ( TO MM20 or COX ) markers directly shows that at least two different metabolic compartments co-exist , side-by-side , within primary tumors and their metastases . | [
"none"
] |
549 | 22395432_10 | Since cancer-associated immune cells appeared glycolytic , this observation may also explain how inflammation literally " fuels " tumor progression and metastatic dissemination , by " feeding " mitochondrial metabolism in cancer cells . | [
"cellular energetics",
"tumor promoting inflammation"
] |
550 | 22395432_11 | Finally , MCT4(+) and TO MM20(-) " glycolytic " cancer cells were rarely observed , indicating that the conventional " Warburg effect " does not frequently occur in cancer-positive lymph node metastases . | [
"cellular energetics",
"activating invasion and metastasis"
] |
551 | 22189713_0 | A distinct group of breast cancers , called " basal " or " triple-negative " ( TN ) cancers express both basal cytokeratins and the epidermal growth factor receptor , but fail to express estrogen receptors , progesterone receptors or HER2 and have stem-like or mesenchymal features . | [
"none"
] |
552 | 22189713_1 | They are particularly aggressive , are frequently chemo-resistant , with p53 mutation , up-regulation of IL-6 and Stat3 . | [
"none"
] |
553 | 22189713_2 | Because TN cells are particularly sensitive to the anti-diabetic agent metformin , we hypothesized that it may target JAK2/Stat3 signaling . | [
"none"
] |
554 | 22189713_3 | The effects of metformin upon Stat3 expression and activation were examined in four human TN cell lines . | [
"none"
] |
555 | 22189713_4 | Metformin's effects were also studied in sublines with forced over-expression of constitutively active ( CA ) Stat3 , as well as lines with stable knockdown of Stat3 . | [
"none"
] |
556 | 22189713_5 | Metformin inhibited Stat3 activation ( P-Stat3 ) at Tyr705 and Ser727 and downstream signaling in each of the four parental cell lines . | [
"none"
] |
557 | 22189713_6 | CA-Stat3 transfection attenuated , whereas Stat3 knockdown enhanced , the effects of metformin upon growth inhibition and apoptosis induction . | [
"resisting cell death"
] |
558 | 22189713_7 | A Stat3 specific inhibitor acted synergistically with metformin in reducing cell growth and inducing apoptosis . | [
"resisting cell death"
] |
559 | 22189713_8 | An mTOR inhibitor showed no significant interaction with metformin . | [
"none"
] |
560 | 22189713_9 | In summary , Stat3 is a critical regulator of metformin action in TN cancer cells , providing the potential for enhancing metformin's efficacy in the clinical setting . | [
"none"
] |
561 | 20632815_0 | AIMS Currently , testing for mismatch repair deficiency in colorectal cancers is initiated by performing immunohistochemistry with four antibodies ( MLH1 , PMS2 , MSH2 and MSH6 ) . | [
"none"
] |
562 | 20632815_1 | If any one of these stains is negative the tumour is considered microsatellite unstable and , if clinical circumstances warrant it , the patient is offered genetic testing for Lynch's syndrome . | [
"none"
] |
563 | 20632815_2 | Due to the binding properties of the mismatch repair heterodimer complexes , gene mutation and loss of MLH1 and MSH2 invariably result in the degradation of PMS2 and MSH6 , respectively , but the converse is not true . | [
"none"
] |
564 | 20632815_3 | We propose that staining for PMS2 and MSH6 alone will be sufficient to detect all cases of mismatch repair deficiency and should replace routine screening with all four antibodies . | [
"none"
] |
565 | 20632815_4 | METHODS The electronic database of the department of Anatomical Pathology , Royal North Shore Hospital , Sydney , Australia , was searched for all colorectal carcinomas on which a four panel immunohistochemical microsatellite instability screen was performed . | [
"none"
] |
566 | 20632815_5 | An audit of the slides for concordant loss of MLH1-PMS2 and MSH2-MSH6 was then undertaken . | [
"none"
] |
567 | 20632815_6 | Unusual or discordant cases were reviewed and , in some cases , re-stained to confirm the staining pattern . | [
"none"
] |
568 | 20632815_7 | RESULTS Of 344 cases of colorectal cancer which underwent four antibody immunohistochemistry , 104 displayed loss of at least one mismatch repair protein . | [
"genomic instability and mutation"
] |
569 | 20632815_8 | Of these , 100 showed concordant mismatch repair loss ( i.e. , loss of MLH1 and PMS2 or loss of MSH2 and MSH6 ) . | [
"genomic instability and mutation"
] |
570 | 20632815_9 | The four discordant cases comprised two single negative cases ( 1 MSH6 negative/MSH2 positive case , 1 PMS2 negative/MLH1 positive ) and two triple negative ( both MLH1/PMS2/MSH6 negative ) . | [
"none"
] |
571 | 20632815_10 | The microsatellite instability ( MSI ) group showed a relatively high median age ( 69.3 years ) due to the departmental policy of testing all cases with possible MSI morphology regardless of age . | [
"none"
] |
572 | 20632815_11 | CONCLUSIONS The sensitivity and specificity of a two panel test comprised of PMS2 and MSH6 , compared to a four panel test , is 100% . | [
"none"
] |
573 | 20632815_12 | No false negatives or positives were identified . | [
"none"
] |
574 | 20632815_13 | We conclude that the two panel test should replace a four panel protocol for immunohistochemical screening for mismatch repair deficiency . | [
"genomic instability and mutation"
] |
575 | 1371284_0 | Lipoprotein lipase ( LPL ) plays a central role in normal lipid metabolism as the key enzyme involved in the hydrolysis of triglycerides present in chylomicrons and very low density lipoproteins . | [
"none"
] |
576 | 1371284_1 | LPL is a member of a family of hydrolytic enzymes that include hepatic lipase and pancreatic lipase . | [
"none"
] |
577 | 1371284_2 | Based on primary sequence homology of LPL to pancreatic lipase , Ser-132 , Asp-156 , and His-241 have been proposed to be part of a domain required for normal enzymic activity . | [
"none"
] |
578 | 1371284_3 | We have analyzed the role of these potential catalytic residues by site-directed mutagenesis and expression of the mutant LPL in human embryonic kidney-293 cells . | [
"none"
] |
579 | 1371284_4 | Substitution of Ser-132 , Asp-156 , and His-241 by several different residues resulted in the expression of an enzyme that lacked both triolein and tributyrin esterase activities . | [
"none"
] |
580 | 1371284_5 | Mutation of other conserved residues , including Ser-97 , Ser-307 , Asp-78 , Asp-371 , Asp-440 , His-93 , and His-439 resulted in the expression of active enzymes . | [
"genomic instability and mutation"
] |
581 | 1371284_6 | Despite their effect on LPL activity , substitutions of Ser-132 , Asp-156 , and His-241 did not change either the heparin affinity or lipid binding properties of the mutant LPL . | [
"none"
] |
582 | 1371284_7 | In summary , mutation of Ser-132 , Asp-156 , and His-241 specifically abolishes total hydrolytic activity without disrupting other important functional domains of LPL . | [
"genomic instability and mutation"
] |
583 | 1371284_8 | These combined results strongly support the conclusion that Ser-132 , Asp-156 , and His-241 form the catalytic triad of LPL and are essential for LPL hydrolytic activity . | [
"none"
] |
584 | 22835516_0 | A 34-year-old Japanese woman presented with left supraclavicular lymph node swelling . | [
"none"
] |
585 | 22835516_1 | Computed tomography scans revealed a mass on the left lower lobe , pulmonary nodules , and pleural effusion . | [
"none"
] |
586 | 22835516_2 | A lymph node biopsy revealed large-cell carcinoma with an epidermal growth factor receptor ( EGFR ) deletion mutation , L747-T751 in exon 19 . | [
"genomic instability and mutation",
"sustaining proliferative signaling"
] |
587 | 22835516_3 | Although malignant pleural effusions carried the same EGFR mutation , progressive pleural effusions after treatment with chemotherapy , gefitinib , and erlotinib did not show any EGFR mutation . | [
"genomic instability and mutation",
"sustaining proliferative signaling"
] |
588 | 22835516_4 | A cell line established from the pleural effusion 3 days before the patient expired also did not harbor the EGFR mutation . | [
"genomic instability and mutation",
"sustaining proliferative signaling"
] |
589 | 22835516_5 | Histological sections of the lymph node of the patient were similar to those of the xenograft tumor of the cell line . | [
"none"
] |
590 | 22835516_6 | There may be genetic heterogeneity in EGFR mutant tumors . | [
"none"
] |
591 | 21975289_0 | BACKGROUND Hepatocellular carcinoma ( HCC ) is the most common liver cancer . | [
"none"
] |
592 | 21975289_1 | Therapeutic results are usually unsatisfactory because liver tumors recur often . | [
"none"
] |
593 | 21975289_2 | Immunologic factors may be related to the recurrence of HCC ; however , this possibility is mentioned only rarely . | [
"none"
] |
594 | 21975289_3 | METHODS Thirty HCC patients undergoing hepatectomies were divided into 3 groups according to the diameters of their HCCs : group A ( n = 8 ) , diameter ≤3 cm ; group B ( n = 8 ) , diameter >3 cm and ≤5 cm ; and group C ( n = 14 ) , diameter >5 cm . | [
"none"
] |
595 | 21975289_4 | T-lymphocytes from peripheral blood , nontumor liver tissue , and the HCC were analyzed . | [
"none"
] |
596 | 21975289_5 | RESULTS The percentage of CD25+ in the CD4+ T cells did not differ between the peripheral blood and the nontumor liver tissue among the 3 groups . | [
"tumor promoting inflammation"
] |
597 | 21975289_6 | CD25+ cells were increased in the tumor tissue in group C patients ( range , 6-41% ; median , 22.9% ; P = .003 ) , compared to group A patients . | [
"none"
] |
598 | 21975289_7 | The percentage of CD25+ in the CD4+ T cells in tumor tissue was positively correlated with tumor sizes ( r = 0.556 ) . | [
"tumor promoting inflammation"
] |
599 | 21975289_8 | These CD4+ CD25+ lymphocytes produced transforming growth factor-β and interferon-γ but not interleukin-10 , and were anergic to plate-coated monoclonal antibodies ( anti-CD3/anti-CD28 ) . | [
"tumor promoting inflammation"
] |
600 | 21975289_9 | The characteristics of these antibodies were comparable to those of regulatory T cells . | [
"tumor promoting inflammation"
] |